Deepak Hegde
| Deepak Hegde | |
|---|---|
.png) Profile picture of Deepak Hegde, Professor of Management at New York University's Stern School of Business (2023).png Hegde in a 2023 lecture | |
| Born | November 5, 1977[1] Yellapur, India[1] |
| 🏳️ Citizenship | United States[1] |
| 💼 Occupation | |
| Title | Seymour Milstein Professor of Strategy Professor of Management |
| 🌐 Website | www |
Deepak Hegde (born November 5, 1977) is an Indian-born American business scholar. He is the Seymour Milstein Professor of Strategy at Stern School of Business, New York University. He is also the founder and director of several entrepreneurship programs. His research and teaching focus on entrepreneurship, innovation, and business strategy. He has received multiple awards for his research and innovative pedagogy.
Hegde's research explores entrepreneurial behavior and innovation policy. He found that workers with skills greater than their resumes show are undervalued by employers and tend to gravitate towards entrepreneurship. Additionally, shared ethnic backgrounds among investors and entrepreneurs lead to superior investment returns. His work on innovation policy revealed that speedy patent approvals for startups significantly boost their growth and success, while increased complexity in the patent approval process can advantage large firms over small ones.
Biography
Early life and education
Hegde was born in Yellapur, Karnataka, India.[1] He earned a Bachelor's degree in industrial engineering from the National Institute of Engineering in 2000.[2] In 2004, he received a master's degree in public policy from the Georgia Institute of Technology,[2] and in 2010, he completed his PhD in Business and Public Policy from the University of California, Berkeley.[3][4]
Academic career
Hegde joined New York University's Stern School of Business as Professor of Management in 2010,[2][5] received tenure in 2016,[6] and became a full professor in 2020.[1][2] In 2023, he was appointed to the chaired professorship Seymour Milstein Professor of Strategy.[2]
Hegde has taught courses on business strategy, innovation, and entrepreneurship.[3][2] He has researched how entrepreneurs and innovators bring their ideas to market.[2][3] His work has been published in journals including Science, Journal of Political Economy, and Management Science.[4][7][2]
Practical entrepreneurship programs
Since 2017, Hegde has launched multiple practical entrepreneurship programs at NYU, aiming to transform ideas into commercially viable startups.[5][8][9][10] In 2019, he launched the NYU Endless Frontier Labs, a nine-month program helping entrepreneurs bridge the gap between science-based ideas and markets.[5][8][9]
Awards and accolades
In 2012, Hegde was named a Kauffman Junior Faculty Fellow.[11] In 2015, he was listed among the top 40 MBA professors under 40 by Poets & Quants.[3][12] In 2022, he received distinguished teaching awards from the NYU Stern School of Business and New York University.[13][14] For his innovative pedagogy, he received the 2018 NYU Stern School of Business Faculty Leadership Award[13] and the 2022 Entrepreneurship Pedagogy Award by the Academy of Management.[15][13]
Research contributions
Hegde's research focuses on the impact of business practices and public policy on innovation and entrepreneurship.[3]
Entrepreneurship
Hegde found that individuals with skills greater than their resumes show are undervalued by employers and tend to become entrepreneurs.[16][17] He also found that venture capitalists are more likely to invest in startups with executives from the same ethnic background, leading to superior investment returns.[3][18][19]
Patent approvals
Hegde's research showed that speedy patent approvals for startups significantly boost their growth and success.[20][21] Conversely, increased complexity in the patent approval process can advantage large firms over small ones.[22]
Patent disclosures
Hegde found that earlier disclosure of inventions by the U.S. Patent and Trademark Office accelerates innovation.[23] He also found that a majority of investors choose to reveal their patent applications publicly.[3][24][25]
Politics of disease research funding
Hegde's research revealed that NIH grant decisions are influenced by lobbying from patient-advocacy groups, leading to greater funding for rare disease research.[26][27][28]
Publications
Journal articles
- Hicks, Diana; Hegde, Deepak (June 2005). "Highly innovative small firms in the markets for technology". Research Policy. 34 (5): 703–716. doi:10.1016/j.respol.2005.03.008. hdl:1853/24060.
- Hegde, Deepak; Mowery, David C (2008). "Politics and funding in the US public biomedical R&D system". Science. 322 (5909): 1797–1798. doi:10.1126/science.1158562. PMID 19095928. Unknown parameter
|s2cid=ignored (help)[29] - Hegde, Deepak; Mowery, David C; Graham, Stuart JH (2009). "Pioneering Inventors or Thicket Builders: Which US Firms Use Continuations in Patenting?". Management Science. 55 (7): 1214–1226. doi:10.1287/mnsc.1090.1016. Unknown parameter
|s2cid=ignored (help)[25]
References
{{reflist|2|refs=
<ref name="Deepak Hegde CV 2023">{{cite web |url=https://www.stern.nyu.edu/faculty/static/cv/cv_dh99_20230531.pdf |title=Deepak Hegde - Curriculum Vitae |last= |first= |date= |website=stern.nyu.edu |publisher= New York University|access-date= |archive-url=https://web.archive.org/web/20230531143427/https://www.stern
- ↑ 1.0 1.1 1.2 1.3 1.4 Cite error: Invalid
<ref>tag; no text was provided for refs namedDeepak Hegde CV 2023 - ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 "NYU Faculty: Deepak Hegde". New York University. 2023. Archived from the original on 2023-05-31. Unknown parameter
|url-status=ignored (help) - ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Baron, Ethan (April 16, 2015). "2015 Best 40 Under 40 Professors: Deepak Hegde, Stern School". poetsandquants.com. Archived from the original on 2015-04-23. Unknown parameter
|url-status=ignored (help) - ↑ 4.0 4.1 Cite error: Invalid
<ref>tag; no text was provided for refs namedUSPTO 2014 - ↑ 5.0 5.1 5.2 5.3 Lebowitz, Shana; Shibu, Sherin; Reuter, Dominick (January 3, 2020). "How to scale a startup and avoid common pitfalls, according to founders and investors who have done it". Business Insider. Archived from the original on 2020-06-12.
Deepak Hegde, associate professor of management and organizations at New York University. Hegde also directs Endless Frontier Labs, which helps technology and science startups scale
Unknown parameter|url-status=ignored (help) - ↑ 6.0 6.1 "NYU Faculty: Deepak Hegde (2016)". New York University. 2016. Archived from the original on 2016-11-02. Unknown parameter
|url-status=ignored (help) - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedGoogle Scholar - ↑ 8.0 8.1 8.2 "Endless Frontier Labs at New York University's Stern School of Business Paves the Way for Science-based Startups". NYU Stern School of Business. July 15, 2019. Archived from the original on 2022-12-04. Unknown parameter
|url-status=ignored (help) - ↑ 9.0 9.1 9.2 The Princeton Review Staff (November 15, 2022). "Top 50 Best Graduate Programs for Entrepreneurs in 2023 - The Princeton Review and Entrepreneur have again partnered to rank the top programs for studying entrepreneurship as a graduate student". Entrepreneur. Archived from the original on 2022-12-04. Unknown parameter
|url-status=ignored (help) - ↑ 10.0 10.1 Bhatia, Ashish K.; Levina, Natalia (August 7, 2020). "Can Entrepreneurship Be Taught in a Classroom?". Harvard Business Review. Archived from the original on 2023-03-26. Unknown parameter
|url-status=ignored (help) - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedKauffman Foundation 2012 - ↑ 12.0 12.1 Carter, Andrea; Baron, Ethan (April 20, 2015). "The 10 top B-school professors under 40". Fortune. Archived from the original on 2022-11-28. Unknown parameter
|url-status=ignored (help) - ↑ 13.0 13.1 13.2 Cite error: Invalid
<ref>tag; no text was provided for refs namedNYU Stern faculty list of awards - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedNYU Distinguished Teaching Awards 2022-2023 - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedAcademy of Management 2022 - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedQuartz 2018 - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedInc.com 2018 - ↑ 18.0 18.1 "Venture Capitalists' Ethnic Favoritism Pays Off for Them". Harvard Business Review. 2014. Archived from the original on 2022-12-03. Unknown parameter
|url-status=ignored (help) - ↑ 19.0 19.1 "Are CEO appointments in India caste/religion biased?". Forbes India. September 14, 2018. Archived from the original on 2023-03-22. Unknown parameter
|url-status=ignored (help) - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedGeorge Mason University 2016 - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedAIM 2016 - ↑ 22.0 22.1 Quittner, Jeremy (July 25, 2014). "A New Study on Patents Confirms the Obvious: Big Businesses Have the Upper Hand - A new study shows a precipitous drop in patent grants over the years. That's bad news for you". Inc. Archived from the original on 2022-12-04. Unknown parameter
|url-status=ignored (help) - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedWritten Description 2018 - ↑ 24.0 24.1 Williams, Heidi L. (January 2017). "How Do Patents Affect Research Investments?" (PDF). NBER Working Paper Series. National Bureau of Economic Research. 9 (23088): 441–469. doi:10.1146/annurev-economics-110216-100959. hdl:1721.1/114175. PMC 5664960. PMID 29104716. Archived from the original (PDF) on 2022-06-30.
- ↑ 25.0 25.1 25.2 Crass, Dirk; Garcia Valero, Francisco; Pitton, Francesco; Rammer, Christian (March 14, 2019). "Protecting Innovation Through Patents and Trade Secrets: Evidence for Firms with a Single Innovation". International Journal of the Economics of Business. 26 (1 - Intellectual Property: Strategy, Measurement, and Economic Performance): 117–156. doi:10.1080/13571516.2019.1553291. Unknown parameter
|s2cid=ignored (help) - ↑ 26.0 26.1 Reardon, Sara (November 6, 2014). "Lobbying sways NIH grants - Pressure on lawmakers from patient-advocacy groups has shaped agency spending on rare-disease research" (PDF). Nature. 515 (7525): 19. doi:10.1038/515019a. PMID 25373655. Archived from the original (PDF) on 2022-12-04. Unknown parameter
|s2cid=ignored (help) - ↑ 27.0 27.1 Silverman, Ed (November 13, 2014). "How Lobbying for Rare Disease Research Influences Congress and NIH". The Wall Street Journal. Archived from the original on 2020-10-27. Unknown parameter
|url-status=ignored (help) - ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedArs Technica 2008 - ↑ 29.0 29.1 Brainard, Jeffrey (December 19, 2008). "Congress Steers NIH Grants to Favored Colleges, Despite Merit-Based Reviews". The Chronicle of Higher Education. Archived from the original on 2022-12-04. Unknown parameter
|url-status=ignored (help) - ↑ Seamans, Robert (June 6, 2017). "Universal Basic Income Is Not An Innovation Policy". Forbes. Archived from the original on 2022-11-14. Unknown parameter
|url-status=ignored (help) - ↑ "NYU Stern $300K Entrepreneurs Challenge Gives Victorious Teams Pathway to Market". americanentrepreneurship.com. June 24, 2020. Archived from the original on 2022-12-07. Unknown parameter
|url-status=ignored (help)
